Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of intravitreal ranibizumab
injection versus low-fluence PDT in the treatment of chronic CSC.